RegenCen
RegenCen is a physician-led regenerative medicine clinic network providing bioidentical hormone replacement therapy, medical weight loss, NAD+ IV therapy, peptide treatments, and PRF regenerative injections to midlife adults across 25+ locations in Michigan, Florida, and South Carolina.
- Company typePrivate
- Founded2001
- HeadquartersTraverse City, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What RegenCen does
RegenCen is a physician-led regenerative and longevity medical clinic network founded in 2001 by Courtney Lo, PA and Gustav Lo, MD, headquartered in Traverse City, Michigan, and operated alongside Cosmetic Skin & Laser Center (CSLC) under the Delaware LLC CSLC MSO Buyer, LLC. The company delivers bioidentical hormone replacement therapy, medical weight loss, NAD+ IV therapy, peptide therapy (including sermorelin), and PRF (Platelet-Rich Fibrin) regenerative injections to midlife adults across 25+ owned clinic locations in Michigan, Florida, and South Carolina, with HIPAA-compliant telehealth for Michigan and Florida patients via Jane.app. Its core proprietary platform is RegenHRT, a trademarked methodology combining baseline lab evaluation, individualized dosing algorithms targeting physiologic (rather than symptomatic) hormone levels, and 3-4 month lab-monitoring cadence, delivered via Biote estrogen pellets, topical/oral/vaginal preparations, and testosterone protocols for both women (perimenopause/menopause) and men (age-related decline). Supporting services include GLP-1-based weight management (semaglutide, tirzepatide), NAD+ IV infusions, peptide protocols, PRF injections for joint pain, hair restoration, and sexual wellness, plus a vaginal rejuvenation suite (FormaV, MorpheusV, VTone). Patient acquisition is consult-first and direct-to-consumer: complimentary initial consultations at physical clinics or via telehealth convert into recurring treatment programs, supported by physician-led community events, blog content, and social media marketing across YouTube, Facebook, and Instagram. Revenue is generated through subscription-recurring hormone therapy, regenerative treatment series with maintenance, usage-based NAD+ IV therapy, and professional services, with no public pricing disclosed and no third-party distributors or institutional investors identified.
RegenCen firmographics
Firmographics- Name
- RegenCen
- Legal name
- CSLC MSO Buyer, LLC
- Website
- https://regencen.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- RegenCen is a physician-led regenerative medicine clinic network providing bioidentical hormone replacement therapy, medical weight loss, NAD+ IV therapy, peptide treatments, and PRF regenerative injections to midlife adults across 25+ locations in Michigan, Florida, and South Carolina.
- Ownership category
- akta.pro rank
RegenCen industry classification
Industry- Product category
- Hormone Therapy and Regenerative Medicine
- NAICS
- Home Health Care Services (621610)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics) (HLAAAGAL)
- akta.pro secondary industry
- Chronic Pain Rehabilitation & Functional Restoration (HSADAIAJ)
Keywords
Where RegenCen is headquartered
LocationHeadquarters
- HQ city
- Traverse City
- HQ country
- United States
- HQ region
- North America
Offices24 records
Markets served
RegenCen business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D
Revenue model
- Consultation Services: Initial consultations (offered as complimentary) that lead to ongoing treatment programs. Consultations assess symptoms, medical history, and goals before recommending personalized treatment plans.
- Hormone Replacement Therapy: Ongoing hormone therapy programs using bioidentical hormones (estrogen, progesterone, testosterone) delivered via pellets, topical creams, oral medications, or vaginal preparations. Requires regular monitoring and follow-up appointments every 3-4 months.
- Medical Weight Loss Programs: GLP-1 medications (semaglutide, tirzepatide) paired with clinical support, lab work, hormone evaluation, and ongoing monitoring. Includes peptide therapies like sermorelin for metabolic optimization.
- Regenerative Treatments: PRF injections for joint pain, hair restoration, and sexual wellness. Treatment series (typically 3 sessions) followed by maintenance appointments every 6-12 months.
- NAD+ IV Therapy: IV infusions of NAD+ for cellular energy, brain function, and anti-aging benefits. Available at all RegenCen locations.
- Guided Aesthetic Care: Co-located with Cosmetic Skin & Laser Center (CSLC), providing access to aesthetic and skin rejuvenation treatments under the same medical platform.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
RegenCen product offering
Product offeringCore offering
RegenCen is a physician-led regenerative medical clinic that delivers bioidentical hormone replacement therapy, regenerative PRF injections, NAD+ IV therapy, peptide therapy, and medically supervised GLP-1 weight loss programs for midlife adults. The company's signature offering is RegenHRT, a proprietary bioidentical hormone replacement protocol combining baseline lab evaluation, individualized dosing, and ongoing lab monitoring every 3–4 months to restore physiologic hormone levels. Services are delivered through 25+ owned clinics in Michigan, Florida, and South Carolina, and via HIPAA-compliant telehealth consultations.
Product overview
RegenCen is a physician-led regenerative and longevity medical clinic offering a multi-modal approach to anti-aging and hormone health. The core platform centers on RegenHRT, the company's proprietary bioidentical hormone replacement therapy methodology, supported by comprehensive lab evaluation, individualized dosing, and ongoing monitoring. This core is extended through complementary services including medical weight loss (semaglutide/tirzepatide GLP-1 programs), NAD+ IV therapy, peptide therapy (sermorelin), and PRF regenerative injections for joint pain, hair restoration, and sexual wellness. The company also provides vaginal rejuvenation treatments (FormaV, MorpheusV, VTone, PRF) and telehealth consultations. Services are delivered across 25+ physical clinic locations in Michigan, Florida, and South Carolina, with virtual care options for existing patients.
Differentiator
Problem solved
Functional benefit
Products and services
- RegenHRT (Bioidentical Hormone Replacement Therapy) RegenCen's proprietary bioidentical hormone replacement therapy program combining comprehensive baseline lab evaluation, individualized dosing using a proprietary algorithm, and ongoing lab monitoring every 3–4 months to maintain physiologic hormone levels. Targets both symptom relief and long-term disease prevention (cardiovascular, osteoporosis). Available to women in perimenopause/menopause and men with hormone decline.
- Testosterone Replacement Therapy (TRT) Personalized testosterone therapy for men with low testosterone symptoms such as fatigue, low libido, weight gain, and brain fog, assessed alongside overall hormone levels and health. Part of the RegenHRT methodology for men.
- Medical Weight Loss Program Medically supervised weight management using GLP-1 medications (semaglutide, tirzepatide), combined with lab work, hormone evaluation, peptide therapy (sermorelin), and ongoing clinical support for sustainable fat loss and metabolic health.
- NAD+ IV Therapy Intravenous NAD+ infusions to restore cellular energy, improve brain function, support metabolism, and slow aging by replenishing NAD+ levels that decline approximately 40% by age 40. Available at all RegenCen clinic locations.
- Peptide Therapy Therapeutic peptide treatments including sermorelin (which stimulates natural growth hormone production via the pituitary gland) and GLP-1 medications for metabolic support, used for energy, recovery, body composition, and healthy aging.
- PRF (Platelet-Rich Fibrin) Injections Next-generation regenerative injection therapy using the patient's own blood. PRF contains more growth factors than PRP and uses no additives or anticoagulants. Applied to joint pain, hair restoration, and sexual wellness, with cited 75% response rate in osteoarthritis research.
- PRF Hair Restoration Scalp injections using platelet-rich fibrin to reactivate dormant hair follicles, improve blood flow, and increase hair density by approximately 30% after three treatment sessions.
- PRF for Joint Pain Regenerative injection therapy for musculoskeletal pain, tendon injuries, and arthritis using platelet-rich fibrin to promote tissue repair and reduce inflammation, with cited 75% response rate in osteoarthritis.
- Vaginal Rejuvenation (FormaV, MorpheusV, VTone, PRF) Suite of physician-supervised treatments for vaginal and pelvic health including radiofrequency (FormaV), microneedling RF (MorpheusV), pelvic floor strengthening (VTone), and PRF for sexual wellness and vaginal rejuvenation. RegenCen is recognized as a top national MorpheusV provider.
- Telehealth Consultations HIPAA-compliant virtual consultations via video and phone for hormone therapy, weight loss programs, and treatment rechecks, available to patients in Michigan and Florida using the Jane.app platform.
- Wellness Consultations Complimentary initial consultations that assess symptoms, medical history, and goals before recommending personalized treatment plans, delivered in-person at clinic locations or virtually.
Quantifiable outcome
- Over 90% of men on testosterone replacement report feeling better overall; 88% report more energy and motivation; 75% report better strength and stamina; 66% report improved sleep; 60% report stronger sex drive
- +4 more outcomes
Companies that use RegenCen
Customer profileSegments5 records
Ideal customer profiles4 records
RegenCen technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
RegenCen partnerships and signals
Strategic signalScale indicators13 records
Recent moves12 records
Expansion highlights4 records
RegenCen competitors and assessment
Company assessmentDirect peers
- Winona: Winona is a women's health platform providing bioidentical hormone replacement therapy, anti-aging treatments, and menopause care via telehealth, overlapping RegenCen's BHRT and women's wellness offerings.
- Midi Health: Midi is a virtual care clinic for women in perimenopause and menopause offering hormone therapy, weight management, and wellness support — a direct competitor for RegenCen's midlife female patient segment via telehealth delivery.
- Evernow: Evernow provides online menopause and perimenopause care including hormone therapy, supplements, and coaching, directly overlapping RegenCen's hormone therapy and women's midlife health services.
- Alloy Women's Health: Alloy is a telehealth platform focused on menopause care, offering hormone therapy and supplements for women in midlife, directly competing for RegenCen's perimenopause/menopause segment.
- BioTE Medical: BioTE is a large national network of certified providers offering bioidentical hormone replacement therapy using subcutaneous pellets, closely mirroring RegenCen's RegenHRT pellet-based approach and physician-led clinic model.
Broad incumbents
- LifeTime Fitness (Hormone & Longevity Services): LifeTime Fitness has expanded into longevity, hormone therapy, and weight management programs through affiliated clinicians, making it a broad incumbent comparable to RegenCen's integrated wellness platform.
- Fountain Life: Fountain Life operates longevity and preventive health centers offering diagnostics, hormone optimization, and regenerative therapies at a premium cash-pay price point, comparable to RegenCen's longevity and anti-aging focus.
- Hims & Hers Health: Hims & Hers is a large telehealth platform offering HRT, weight loss (GLP-1s), and wellness products, broadly competing with RegenCen's hormone therapy and GLP-1 weight loss services at scale.
Emerging players
- Tia (Women's Health): Tia operates women's health clinics offering primary care, gynecology, and menopause support with a focus on midlife women, comparable to RegenCen's physician-led women's health and hormone therapy positioning.
- Next Health: Next Health runs membership-based wellness and longevity clinics offering IV therapy, hormone optimization, and regenerative services, partially overlapping RegenCen's NAD+, peptide, and hormone therapy offerings.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
RegenCen social profiles
Digital presenceRegenCen compliance and trust
Trust signalCompliance1 record
RegenCen financial estimates
Financial estimateRevenue estimate
Valuation estimate
RegenCen leadership team
Management profileNumber of profiles
Profiles4 records
RegenCen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RegenCen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RegenCen
What does RegenCen do?
RegenCen is a physician-led regenerative medical clinic that delivers bioidentical hormone replacement therapy, regenerative PRF injections, NAD+ IV therapy, peptide therapy, and medically supervised GLP-1 weight loss programs for midlife adults. The company's signature offering is RegenHRT, a proprietary bioidentical hormone replacement protocol combining baseline lab evaluation, individualized dosing, and ongoing lab monitoring every 3–4 months to restore physiologic hormone levels. Services are delivered through 25+ owned clinics in Michigan, Florida, and South Carolina, and via HIPAA-compliant telehealth consultations.
Is RegenCen a public or private company?
RegenCen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RegenCen founded?
RegenCen was founded in 2001. It employs 11 to 50 people.
Where is RegenCen based?
RegenCen is headquartered in Traverse City, United States, in the North America region.
How does RegenCen make money?
Six revenue lines are on record. Consultation Services are the primary driver. The others are hormone Replacement Therapy, medical Weight Loss Programs, regenerative Treatments, NAD+ IV Therapy and guided Aesthetic Care.
Who are RegenCen's main competitors?
Direct peers on record are Winona, Midi Health, Evernow, Alloy Women's Health and BioTE Medical. Broad incumbents are LifeTime Fitness (Hormone & Longevity Services), Fountain Life and Hims & Hers Health. Emerging players are Tia (Women's Health) and Next Health.
Does RegenCen have an API?
No public API is recorded for RegenCen.
What industry is RegenCen in?
RegenCen's product category is Hormone Therapy and Regenerative Medicine. Its primary akta.pro industry code is HLAAAGAL, Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics), with a secondary code of HSADAIAJ, Chronic Pain Rehabilitation & Functional Restoration. Its NAICS code is 621610 and its SIC code is 8090.